G. Brattsand et al., QUANTITATIVE-ANALYSIS OF THE EXPRESSION AND REGULATION OF AN ACTIVATION-REGULATED PHOSPHOPROTEIN (ONCOPROTEIN 18) IN NORMAL AND NEOPLASTIC-CELLS, Leukemia, 7(4), 1993, pp. 569-579
Activation of protein kinase C results in phosphorylation of a 19-kDa
protein termed 19K. Isolation and sequence analysis of a cDNA encoding
the 19K protein revealed that this protein has been studied in other
systems under different names. The name oncoprotein 18 (Op18) has been
proposed on the basis of a postulated up-regulation in neoplastic cel
ls. In the present report we adopt the designation Op18 for the 19K pr
otein, and quantify this phosphoprotein in a series of leukemia/lympho
ma cell lines, a panel of non-transformed cells and some terminally di
fferentiated cell types. For this purpose we have developed reagents a
llowing quantitative Western-blot analysis, and quantification of Op18
on the single cell level by flow cytometric analysis. The data demons
trates a pronounced up-regulation of the Op18 protein in most leukemia
/lymphoma cell lines. The HPB-ALL cell line provided the most extreme
case and expressed 7 x 10(6) Op18 molecules/cell, which compares with
0.65 x 10(6) Op18 molecules/cell in non-transformed lymphoblastoid cel
ls. The expression of Op18 appears to be restricted to cell types with
proliferative potential, but it is clear from our results that up-reg
ulation of Op18 is uncoupled from cellular proliferation. Moreover, by
employing an Epstein-Barr virus based shuttle vector, we expressed Op
18 cDNA in lymphoblastoid cells. This resulted in a three to fourfold
up-regulation of Op18 that did not have any detectable consequences fo
r cell-surface phenotype or cell size. However, increased expression o
f Op18 resulted in a partial inhibition of cell proliferation. Taken a
ltogether, the results suggest that up-regulated Op18 levels in leukem
ia/lymphoma cells are strongly associated with, but not a direct cause
of tumour progression.